Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Safely Scaling Highly Potent API manufacturing
Ever more drug developers are searching for CDMOs with contamination-limiting capabilities. But how can they know which have these high-potency credentials? read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more
The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy
An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still reopening cases the system had already cleared. read more
An Interview with Rod Ketner, PhD
Sponsors sometimes optimize too narrowly for the next milestone instead of the full development path. A formulation may be sufficient for an early study but still be poorly positioned for robust scale-up, transfer, or validation. That’s where delays and added costs show up. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

LGM Pharma Acquires Sannova Analytical to Expand Testing Services
Thursday, October 22, 2026
LGM Pharma has acquired Sannova Analytical, a contract research laboratory in Somerset, New Jersey, adding bioanalytical services and specialized ... read more
Medpace Revenue Rises 8.5%; Board Approves $1 Billion Buyback
Thursday, October 22, 2026
Medpace reported third-quarter revenue of $716 million, up 8.5% from a year earlier, while net income increased to $137.5 million from $111.1 million.... read more
Zylidac, Prolific Partner on Light-Controlled Biologics Manufacturing
Wednesday, October 21, 2026
Zylidac Bio and Prolific Machines have partnered to move Prolific’s light-controlled protein production technology from laboratory development toward ... read more
Touchlight Names Downie Interim CEO as Fallen Steps Down
Wednesday, October 21, 2026
Touchlight has appointed Will Downie as interim chief executive officer, replacing Karen Fallen, who is stepping down after leading the company since ... read more
Kindeva Wins Nerve Agent Autoinjector Contract Worth Up to $226 Million
Tuesday, October 20, 2026
Kindeva’s Meridian Medical Technologies division has received a Defense Logistics Agency contract worth up to $226 million to supply nerve agent ... read more